SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-016698
Filing Date
2021-12-13
Accepted
2021-12-13 06:02:10
Documents
12
Period of Report
2021-12-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K aytu-20211208x8k.htm   iXBRL 8-K 31908
  Complete submission text file 0001558370-21-016698.txt   151390

Data Files

Seq Description Document Type Size
2 EX-101.SCH aytu-20211208.xsd EX-101.SCH 3035
3 EX-101.LAB aytu-20211208_lab.xml EX-101.LAB 16081
4 EX-101.PRE aytu-20211208_pre.xml EX-101.PRE 10212
5 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20211208x8k_htm.xml XML 4861
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 211486857
SIC: 2834 Pharmaceutical Preparations